Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Anticoagulant on Early Treatment of Post-STEMI Left Ventricular Thrombus: an Open, Prospective, Randomized and Multi-centers Trial.

NCT03764241 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT03764241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Anticoagulant on Early Treatment of Post-STEMI Left Ventricular Thrombus: an Open, Prospective, Randomized and Multi-centers Trial.
Lead sponsor
RenJi Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
February 1, 2020
Completion date
December 30, 2023
Enrollment
280 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

left ventricular thrombus, st segment elevation myocardial infarction